V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20159608 | 20061329 | 1.8 | 53 | Neo-adjuvant (N) | 2017-12-29 | 2018-01-01 | ECX | 2 | N | ECX | 101518037 |
| 20159610 | 20061330 | 1.55 | 52 | Neo-adjuvant (N) | 2018-05-19 | 2018-05-27 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101532832 |
| 20159611 | 20061331 | 1.84 | 60.8 | Neo-adjuvant (N) | 2019-10-31 | 2019-11-08 | ECX | 02 | N | ECX | 100891870 |
| 20159613 | 20061332 | 1.6 | 41 | Palliative (P) | 2017-01-21 | 2017-02-11 | ECX | N | N | ECX | 100632054 |
| 20159617 | 20061333 | 1.47 | 48.9 | Neo-adjuvant (N) | 2019-05-13 | 2019-05-27 | ECX | 02 | N | ECX | 100459460 |
| 20159620 | 20061334 | 1.64 | 69.1 | Neo-adjuvant (N) | 2017-05-26 | 2017-06-05 | ECX | N | N | ECX | 100404340 |
| 20159621 | 20061335 | 1.7 | 75 | Neo-adjuvant (N) | 2019-03-23 | 2019-03-23 | ECX | N | N | ECX | 101716244 |
| 20159623 | 20061336 | 1.69 | 62 | Neo-adjuvant (N) | 2017-01-02 | 2017-01-04 | ECX | 02 | N | ECX | 100663626 |
| 20159625 | 20061337 | null | 55.35 | Disease modification (D) | 2016-09-16 | 2016-09-23 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100329866 |
| 20159626 | 20061338 | 1.73 | 84.6 | Curative (C) | 2016-07-11 | 2016-07-25 | ECX | 02 | N | ECX | 101724765 |
| 20159627 | 20061339 | 1.76 | 82 | Adjuvant (A) | 2017-11-17 | 2017-12-02 | ECX | N | N | ECX | 100915878 |
| 20159629 | 20061340 | 1.68 | 83.15 | Palliative (P) | 2017-07-03 | 2017-07-06 | ECX | N | N | ECX | 101816425 |
| 20159631 | 20061341 | 1.66 | 51.8 | Neo-adjuvant (N) | 2020-01-21 | 2020-01-28 | ECX | 02 | N | ECX | 101509440 |
| 20159632 | 20061342 | null | null | Palliative (P) | 2017-07-11 | 2017-07-11 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100291344 |
| 20159633 | 20061343 | 1.56 | 80.8 | Palliative (P) | 2018-02-24 | 2018-03-05 | ECX | N | N | ECX | 100370070 |
| 20159635 | 20061344 | 1.78 | 85 | Neo-adjuvant (N) | 2018-05-09 | 2018-05-16 | ECX | 2 | N | ECX | 100062301 |
| 20159636 | 20061345 | 1.58 | 51 | Adjuvant (A) | 2017-01-12 | 2017-01-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101193771 |
| 20159637 | 20061346 | 1.61 | 63.2 | Adjuvant (A) | 2017-10-30 | 2017-11-03 | CAPECITABINE + GEMCITABINE | 2 | N | CAPECITABINE + GEMCITABINE | 100672745 |
| 20159638 | 20061347 | 1.56 | 69 | Palliative (P) | 2019-01-21 | 2019-01-21 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101155406 |
| 20159639 | 20061348 | 1.79 | 64 | Palliative (P) | 2019-06-02 | 2019-06-05 | ECX | N | N | ECX | 100614303 |
| 20159640 | 20061349 | 1.86 | 90 | Adjuvant (A) | 2016-04-17 | 2016-04-28 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100753661 |
| 20159641 | 20061350 | 1.75 | 66 | Neo-adjuvant (N) | 2016-12-05 | 2016-12-06 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100217028 |
| 20159643 | 20061351 | null | null | Neo-adjuvant (N) | 2016-10-29 | 2016-11-12 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101039249 |
| 20159645 | 20061352 | 1.68 | 66.4 | Palliative (P) | 2018-11-23 | 2018-11-23 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 101058323 |
| 20159647 | 20061353 | 1.69 | 91 | Neo-adjuvant (N) | 2018-03-19 | 2018-03-30 | ECX | N | N | ECX | 101540935 |
| 20159648 | 20061354 | 1.77 | 70.3 | Palliative (P) | 2019-04-10 | 2019-04-21 | ECX | N | N | ECX | 100984142 |
| 20159650 | 20061355 | 1.98 | 73 | Adjuvant (A) | null | 2016-07-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100462696 |
| 20159651 | 20061356 | 1.8 | 82.5 | null | 2018-04-13 | 2018-04-19 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101852270 |
| 20159652 | 20061357 | 1.69 | 94 | Palliative (P) | 2018-06-05 | 2018-07-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101234601 |
| 20159653 | 20061358 | 1.77 | 59.8 | Adjuvant (A) | 2018-08-01 | 2018-08-18 | ECX | N | N | ECX | 100185699 |
| 20159654 | 20061359 | 1.63 | 78.55 | Neo-adjuvant (N) | null | 2016-04-20 | Gemcitabine + Capecitabine | null | N | ECX | 100132482 |
| 20159656 | 20061360 | 1.83 | 70.4 | Neo-adjuvant (N) | 2018-10-05 | 2018-10-20 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100683506 |
| 20159659 | 20061361 | 1.63 | 70 | Curative (C) | 2019-04-23 | 2019-04-30 | ECX | 02 | Y | ECX | 101469471 |
| 20159662 | 20061362 | 1.69 | 58.2 | Neo-adjuvant (N) | 2018-03-21 | 2018-04-04 | ECX | N | N | ECX | 101330417 |
| 20159666 | 20061363 | 1.54 | 79.8 | Palliative (P) | 2019-12-26 | 2020-01-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101523153 |
| 20159667 | 20061364 | 1.76 | 57.4 | null | 2017-06-06 | 2017-06-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101726540 |
| 20159668 | 20061365 | 1.66 | 43.6 | Palliative (P) | 2019-05-07 | 2019-06-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100935682 |
| 20159669 | 20061366 | 1.72 | 89.8 | null | 2018-07-15 | 2018-08-29 | ECX | 2 | N | ECX | 100964710 |
| 20159671 | 20061367 | 1.62 | 77 | Palliative (P) | 2018-03-23 | 2018-04-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100364882 |
| 20159673 | 20061368 | 1.76 | 73.2 | Neo-adjuvant (N) | 2018-09-06 | 2018-09-06 | ECX | N | N | ECX | 100051628 |
| 20159676 | 20061369 | 1.7 | 57.9 | Palliative (P) | 2017-04-29 | 2017-05-13 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100354067 |
| 20159678 | 20061370 | 1.72 | 76.2 | Adjuvant (A) | 2017-04-07 | 2017-04-22 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100762192 |
| 20159680 | 20061371 | 1.65 | 116 | Neo-adjuvant (N) | 2016-07-29 | 2016-07-29 | ECX | N | N | ECX | 101631939 |
| 20159683 | 20061372 | 1.6 | 57.2 | Palliative (P) | 2019-03-04 | 2019-03-18 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101253356 |
| 20159684 | 20061373 | 1.67 | 60.9 | Neo-adjuvant (N) | 2016-11-12 | 2016-12-07 | ECX | N | N | ECX | 100555277 |
| 20159685 | 20061374 | 1.58 | 76.4 | Adjuvant (A) | 2017-09-17 | 2017-10-11 | ECX | N | null | ECX | 100994348 |
| 20159687 | 20061375 | 1.69 | 88 | Adjuvant (A) | 2019-04-13 | 2019-04-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100361612 |
| 20159689 | 20061376 | 1.56 | 115 | Adjuvant (A) | 2017-12-05 | 2017-12-14 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101285879 |
| 20159690 | 20061377 | 1.58 | 94 | Neo-adjuvant (N) | 2019-11-28 | 2019-12-01 | ECX | N | N | ECX | 101462434 |
| 20159691 | 20061378 | 1.8 | 82.5 | Neo-adjuvant (N) | 2016-08-12 | 2016-08-16 | ECX | N | N | ECX | 101360914 |